Loading…Loading content
Systemic sclerosis is an uncommon disease in which the immune system drives scarring. The skin thickens, small blood vessels narrow so that fingers go white and painful in the cold, and the same process can stiffen the lungs, damage the kidneys or slow the gut. It shortens life, and how much depends on which organs are involved and how early anyone noticed. Outcomes are not spread evenly. Papers report differences in how long a diagnosis takes, who reaches a specialist centre, which treatments are started and how long people live, tracking along ethnicity, income, insurance, language and distance from a hospital. How much of that gap is the disease behaving differently and how much is care reaching people differently is unresolved, and the studies are hard to line up: a specialist centre, a national registry and an insurance database are not looking at the same population, and each measures disadvantage its own way. This review reads that literature by the step in the pathway where the difference shows up. What it can settle is which gaps are documented and which are only assumed.
Read up on systemic sclerosis and on how studies measure social and economic disadvantage. Take one step of the care pathway, read the studies reporting it, build the table that goes with them, and write that section.
You apply with your university account: your CV and a motivation letter written on the platform.
Sign in to apply